ACT-AD Chairman Daniel Perry Interviewed by BioCentury This Week

ACT-AD Chairman Daniel Perry is interviewed by BioCentury This Week to share his thoughts on U.S. funding of Alzheimer’s research and the use of biomarkers to speed Alzheimer’s therapy development. During the interview, Mr. Perry commends the Obama Administration for repurposing and committing additional funds for Alzheimer’s research, but says additional steps must be taken to help speed the delivery of better treatments and cures to those in need.